Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Zentalis Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $15.2M in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$15.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Zentalis Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Zentalis Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Walters Group10% Owner17,844,973Aug 19, 20262
Walters William Thurman10% Owner17,844,973Aug 19, 20262
Walters Susan Berkley10% Owner17,844,973Aug 19, 20262
Myers Scott DunsethDirector395,895Jun 18, 20261
Walker Luke NathanielDirector201,384Jun 18, 20261
Johnson David MichaelDirector307,521Jun 18, 20261
Skvarka JanDirector264,254Jun 18, 20261
Kariuki EnochDirector194,465Jun 18, 20261
Campbell ShannonDirector114,200May 27, 20261
Eastland Julia MarieCEO & President79,133Feb 10, 20262
Bruns IngmarChief Medical Officer33,332Feb 10, 20262
Vultaggio VincentPAO and PFO146,506Feb 10, 20263
Bucher James BChief Legal Officer–Jan 9, 20262
Matrix Capital Management Company, LP10% Owner6,459,973IndirectDec 15, 20251
Goel David E.10% Owner6,459,973IndirectDec 15, 20251
Lackner MarkChief Scientific Officer512,856Feb 5, 20250
Paul AndreaChief Legal Officer1,070,784Feb 5, 20250
Gallagher CamPresident, Interim CFO633,680May 31, 20240
Hausman DianaChief Medical Officer373,876May 9, 20240
Epperly Melissa B,Chief Financial Officer451,449Feb 12, 20240
Blackwell KimberlyChief Executive Officer484,145Feb 5, 20240
Bunker Kevin D.Chief Scientific Officer834,931Dec 21, 20230
Brownstein CarrieChief Medical Officer105,685Oct 6, 20230
Roth IrisChief Operating Officer52,500Mar 2, 20230
Sun Anthony YPresident & CEO1,175,589Apr 5, 20220
Voliotis DimitrisSVP, Clinical Development15,978Feb 14, 20220
Pinto AlexisChief Legal Officer22,240Feb 14, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 19, 2026 (view filing)6:11 PM ETAug 145 daysLateWalters Group and 2 others10% OwnerPPurchase+4.33M$3.50+$15.2M+32.1%17.8M after
Feb 10, 2026 (view filing)Feb 6-104 daysVultaggio VincentPAO and PFOSSale−40.2K$2.42−$97.5K−21.5%146.5K after3 lots10b5-1
Feb 10, 2026 (view filing)Feb 6-94 daysBruns IngmarChief Medical OfficerSSale−3.30K$2.43−$8.00K−9.0%33.3K after2 lots
Feb 10, 2026 (view filing)Feb 6-94 daysEastland Julia MarieCEO & PresidentSSale−8.76K$2.43−$21.2K−10.0%79.1K after2 lots
Feb 4, 2026 (view filing)Feb 2-32 daysVultaggio VincentPAO and PFOSSale−3.10K$2.54−$7.88K−1.6%186.7K after2 lots10b5-1
Jan 8, 2026 (view filing)4:57 PM ETDec 31, 20258 daysLateWalters Group and 2 others10% OwnerPPurchase+6.46M$1.20+$7.75M+91.6%13.5M after
Dec 15, 2025 (view filing)5:24 PM ETDec 15Same dayMatrix Capital Management Company, LP and 1 other10% OwnerSSaleCommon Stock, par value $0.001 per share−7.50M$1.33−$9.97M−53.7%6.46M after
Apr 30, 2025 (view filing)Apr 30Same dayMyers Scott DunsethDirectorPPurchase+21.0K$1.40+$29.4K+8.1%281.2K after
Feb 12, 2025 (view filing)Feb 66 daysLateBruns IngmarChief Medical OfficerPPurchase+20.0K$2.28+$45.6K+120.3%36.6K after
Feb 5, 2025 (view filing)Feb 32 daysVultaggio VincentPAO and Interim PFOSSale−2.62K$1.71−$4.47K−1.4%189.8K after
Feb 5, 2025 (view filing)Feb 32 daysLackner MarkChief Scientific OfficerSSale−14.4K$1.71−$24.6K−2.7%512.9K after
Feb 5, 2025 (view filing)Feb 32 daysPaul AndreaChief Legal OfficerSSale−13.2K$1.71−$22.6K−1.2%1.07M after
Feb 4, 2025 (view filing)Jan 314 daysSkvarka JanDirectorPPurchase+60.0K$1.72+$103.2K+67.0%149.6K after
Feb 4, 2025 (view filing)Jan 314 daysWalker Luke NathanielDirectorPPurchase+14.2K$1.76+$25.0K+19.6%86.7K after
Feb 4, 2025 (view filing)Jan 314 daysEastland Julia MarieCEO & PresidentPPurchase+28.5K$1.73+$49.3KNew position28.5K after
Jan 3, 2025 (view filing)Jan 21 dayLackner MarkChief Scientific OfficerSSale−4.41K$3.12−$13.8K−2.3%191.3K after
Oct 4, 2024 (view filing)Oct 4Same dayVultaggio VincentPrincipal Accounting OfficerSSale−1.60K$3.18−$5.10K−4.5%33.9K after10b5-1
May 31, 2024 (view filing)May 31Same dayGallagher CamPresident, Interim CFOSSale−9.60K$11.98−$115.0K−1.5%633.7K after
May 9, 2024 (view filing)May 9Same dayHausman DianaChief Medical OfficerSSale−3.36K$12.62−$42.4K−0.9%373.9K after
Feb 12, 2024 (view filing)Feb 12Same dayEpperly Melissa B,Chief Financial OfficerSSale−2.57K$11.44−$29.4K−0.6%451.4K after
Feb 12, 2024 (view filing)Feb 12Same dayGallagher CamPresidentSSale−1.17K$11.44−$13.4K−0.2%643.3K after
Feb 5, 2024 (view filing)Feb 23 daysLackner MarkChief Scientific OfficerSSale−1.58K$11.54−$18.3K−0.8%195.7K after
Feb 5, 2024 (view filing)Feb 23 daysPaul AndreaChief Legal OfficerSSale−3.31K$11.54−$38.2K−2.2%150.0K after
Feb 5, 2024 (view filing)Feb 23 daysGallagher CamPresidentSSale−11.6K$11.54−$133.3K−1.8%644.5K after
Feb 5, 2024 (view filing)Feb 23 daysEpperly Melissa B,Chief Financial OfficerSSale−8.67K$11.54−$100.0K−1.9%454.0K after
Nov 13, 2023 (view filing)Nov 103 daysJohnson David MichaelDirectorPPurchase+17.0K$9.88+$168.0K+13.3%144.4K after
Nov 13, 2023 (view filing)Nov 13Same dayBlackwell KimberlyChief Executive OfficerPPurchase+5.00K$10.29+$51.5K+2.0%254.8K after
Oct 6, 2023 (view filing)Oct 42 daysBrownstein CarrieChief Medical OfficerSSale−10.6K$19.51−$207.3K−9.1%105.7K after2 lots10b5-1
Oct 6, 2023 (view filing)Oct 42 daysBunker Kevin D.Chief Scientific OfficerSSale−6.07K$19.51−$118.4K−0.7%859.1K after2 lots10b5-1
Oct 6, 2023 (view filing)Oct 42 daysEpperly Melissa B,Chief Financial OfficerSSale−5.48K$19.51−$106.9K−1.4%387.7K after2 lots10b5-1
Sep 13, 2023 (view filing)Sep 112 daysSkvarka JanDirectorSSale−5.00K$25.05−$125.3K−9.4%48.0K after10b5-1
Jun 20, 2023 (view filing)4:30 PM ETJun 20Same dayMatrix Capital Management Company, LP and 1 other10% OwnerPPurchaseCommon Stock, par value $0.001 per share+4.76M$22.66+$107.9M+51.7%14.0M after
May 31, 2023 (view filing)May 31Same dayGallagher CamPresidentSSale−27.8K$26.27−$729.6K−5.7%463.5K after2 lots10b5-1
May 31, 2023 (view filing)May 265 daysBunker Kevin D.Chief Scientific OfficerSSale−80.0K$30.02−$2.40M−84.2%15.0K after10b5-1
Feb 14, 2023 (view filing)Feb 13-141 dayEpperly Melissa B,Chief Financial OfficerSSale−7.85K$20.13−$158.0K−2.0%392.0K after2 lots
Feb 14, 2023 (view filing)Feb 13-141 dayGallagher CamPresidentSSale−11.8K$20.09−$237.7K−2.4%491.3K after2 lots
Feb 14, 2023 (view filing)Feb 13-141 dayBunker Kevin D.Chief Scientific OfficerSSale−10.3K$20.14−$207.6K−1.2%865.2K after2 lots
Feb 6, 2023 (view filing)Feb 6Same dayGallagher CamPresidentSSale−10.0K$22.27−$222.7K−1.9%503.1K after2 lots
Jan 18, 2023 (view filing)Jan 171 dayGallagher CamPresidentSSale−10.0K$24.15−$241.5K−2.8%352.0K after2 lots
Jan 5, 2023 (view filing)Jan 5Same dayGallagher CamPresidentSSale−10.0K$21.02−$210.2K−2.7%362.0K after2 lots
Nov 15, 2022 (view filing)Nov 15Same dayGallagher CamPresidentSSale−12.5K$22.77−$284.7K−3.3%372.0K after2 lots
Nov 8, 2022 (view filing)Nov 7-81 dayGallagher CamPresidentSSale−24.9K$23.61−$587.4K−6.1%384.5K after3 lots
Oct 17, 2022 (view filing)Oct 17Same dayGallagher CamPresidentSSale−12.5K$23.51−$293.9K−3.0%409.4K after
Oct 7, 2022 (view filing)Oct 5-62 daysGallagher CamPresidentSSale−22.5K$22.45−$505.2K−5.1%421.9K after3 lots
Sep 16, 2022 (view filing)Sep 15-161 dayGallagher CamPresidentSSale−22.5K$24.90−$560.2K−4.8%444.4K after4 lots
Aug 12, 2022 (view filing)Aug 102 daysBunker Kevin D.Chief Operating OfficerSSale−5.00K$30.00−$150.0K−5.0%95.0K after
Jul 20, 2022 (view filing)Jul 20Same dayBunker Kevin D.Chief Operating OfficerSSale−5.00K$30.00−$150.0K−4.8%100.0K after
Jul 14, 2022 (view filing)Jul 13-141 dayBunker Kevin D.Chief Operating OfficerSSale−5.00K$30.01−$150.1K−4.5%105.0K after2 lots
Jul 6, 2022 (view filing)Jul 51 dayBunker Kevin D.Chief Operating OfficerSSale−25.0K$30.07−$751.8K−18.5%110.0K after
Apr 13, 2022 (view filing)Apr 112 daysBunker Kevin D.Chief Operating OfficerSSale−5.00K$30.55−$152.7K−3.6%135.0K after3 lots